Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CloBu4 Conditioning for Non-remission AML
NCT01457885Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Nov 2011
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by University of Michigan Rogel Cancer Center. Started Nov 2011; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01457885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01457885.